mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.008 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |